The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer
Crossref DOI link: https://doi.org/10.1007/s00259-017-3681-9
Published Online: 2017-03-23
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yordanova, Anna
Becker, Anja
Eppard, Elisabeth
Kürpig, Stefan
Fisang, Christian
Feldmann, Georg
Essler, Markus
Ahmadzadehfar, Hojjat
License valid from 2017-03-23